Palvella Therapeutics, Inc. · NASDAQ:PVLA
Montanova Capital, LLC reported a 8.60% stake in Palvella Therapeutics, Inc. (Schedule 13G)
Event Dec 13, 2024 · Filed Dec 20, 2024
Montanova Capital, LLC reported a 8.60% stake in Palvella Therapeutics, Inc., 714,463 shares, as a passive investor on Dec 13, 2024. Filed Dec 20, 2024 (Schedule 13G).
- Stake
- 8.60%
- Shares
- 714,463
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 8.60% | 714,463 |
| Averill Master Fund, Ltd. | 8.60% | 714,463 |
| Aaron Cowen | 8.60% | 714,463 |
Source
Related
- Palvella Therapeutics, Inc.
- Montanova Capital, LLC
- Palvella Therapeutics, Inc. shareholders
- Schedule 13G/A · Montanova Capital, LLC · Nov 13, 2025
- Form 4 · Goin Kathleen · Oct 23, 2026
- Form 4 · Jenkins George M · Oct 14, 2026
- Form 4 · Goin Kathleen · Sep 18, 2026
- Form 4 · Jenkins George M · Sep 15, 2026
- Form 4 · Kiritsy Christopher P · Sep 4, 2026